By ADITHI RAMAKRISHNAN, AP Science Writer
NEW YORK (AP) — Over 74,000 people enrolled in experiments have been affected by the National Institutes of Health’s funding cuts , according to a new report.
Between the end of February and mid-August, funding ceased for 383 studies that were testing treatments for conditions including cancer, heart disease and brain disease. The cuts disproportionately impacted efforts to tackle infectious diseases like the flu, pneumonia and COVID-19, researchers found.
The funding cuts likely disrupted patients’ lives in different ways.
Some may have signed up for trials that never began or got delayed as institutions scrambled for alternate funding. Others could have lost access to medication or been left with an unmonitored device implant.
More s

The Oakland Press

Associated Press US News
AlterNet
The Conversation
Reuters US Business
People Top Story
Fortune
Healthcare Dive
Atlanta Black Star Entertainment